norm: cytokineticsNAICS Pharmaceutical Preparations · USLEI 549300BE5DY1HW7IHA64 · CIK 0001061983Max severity: Low

Canonical registry

CYTOKINETICS INC

ent_019e45ac0268ddf6f6132579efaa421a

Compliance scorecard →🔔 Follow entity

Disclosures

1

SEC 10-K Item 1C · 1 jurisdiction

Incidents

—

no linked incident in sample

Max affected reported

—

no filed count in sample

Leak-site claims

0

none in sample

Identity resolution

Canonical name: CYTOKINETICS INC
Normalized: cytokinetics— dedupe via name-norm; Microsoft / MSFT collapse to one row
GLEIF LEI: 549300BE5DY1HW7IHA64
SEC EDGAR CIK: 0001061983
Domain: None on record

Disclosure history (1)newest first

FEDERALSEC 10-K Item 1Cas victim2024-02-28
Cytokinetics' 10-K Item 1C cybersecurity disclosure describes the company's risk management framework, governance structure, and oversight mechanisms for cybersecurity threats. No specific cybersecurity incident is disclosed. The document outlines the roles of the CISO, VP of IT, CEO, CFO, and Audit Committee in managing cybersecurity risk.